Seòmar agus comataidhean

We are committed to reducing the impact of inequalities on health outcomes for people living with diabetes, and equity of access is highlighted as a key priority in our Diabetes Improvement Plan refresh, published in February 2021.

We are working with key partners including NHS Boards, Health & Social Care Partnerships, Diabetes Scotland and people living with diabetes to ensure that evolving care models address existing health inequalities by integrating pathways with existing services and resources such as social work, mental health services, education and third sector.

As diabetes services evolve and include more virtual offerings, we will work to ensure that those people with diabetes who are unable to access services digitally are not disadvantaged as a result of digital exclusion.

The scoping exercise referred to in S6W-04556 will help the Scottish Government to establish current service provision for miscarriage care and support that is available to women who experience unexpected pregnancy complications across all 14 Health Boards and will issue shortly. The issue of the questionnaire has been delayed due to service pressures within the NHS because of the ongoing pandemic. The first roundtable is expected to take place in March 2022 and we plan to invite health professionals and baby loss charities as well as inviting bereaved parents to share their experiences.

This information is not held centrally. A scoping exercise of NHS Boards in respect of services for miscarriage and unexpected pregnancy complications was paused in light of service pressures due to the COVID-19 pandemic. Subject to sustained improvement in the pandemic we intend to issue this shortly.

We know this is a difficult time for travel agents and we have had to make tough decisions to target funding to sectors immediately impacted by the updated public health guidance.

Since the start of the pandemic, businesses have benefitted from more than £4.4bn in support from the Scottish Government. This includes support for travel agents who benefited from sectoral grants of up to £25,000 per premises this year in addition to other support including the Strategic Framework Business Fund grants, Restart Grants, Contingency Fund, Non-Domestic Rates relief and furlough payments for staff.

We recently announced £375m of support for businesses impacted by the necessary public health measures introduced to control the spread of Omicron and have provided details on how £276 million of this will be allocated. Decisions on the allocation of the remaining funds will be confirmed following further consultation with affected sectors on how it can best be targeted.

The Scottish Government used a range of sources of evidence when determining the latest isolation policy changes including data on various key aspects of the pandemic including vaccination rates; clinical advice from senior clinicians including the Chief Medical Officer, PHS public health clinicians, the National Incident Management Team and UKHSA analysis.

In addition, the Scottish Government considered the effects on key workforces and service, including health and social care, of retaining the same isolation policy.

The Scottish Government and NHS recognise the importance of ensuring cervical screening is accessible. Every sample taker is therefore required to undertake training provided by NHS Education for Scotland, and guidance is provided to account for each screening participants needs. This guidance includes making the appropriate adjustments, including those required for disabled women, to ensure that samples can be taken from all eligible women invited for screening. As part of our on-going commitment to providing the best service, in the coming months, the screening programme will explore additional steps to improve the experience for disabled women.

SEPA maintains a robust programme structure to plan, track, and deliver the regulator function for Scotland’s Deposit Return Scheme (DRS), including delivery of a producer registration system. SEPA is making good progress in establishing this system in time to meet the January 2023 milestone that the Scottish Government published in December 2021.

We recognise that the Covid-19 pandemic has had a significant impact on our NHS including diabetes services. We took the opportunity to reflect on these challenges as we determined the priorities for our Diabetes Improvement Plan refresh, which was published in February 2021.

On 25 August 2021 we launched our NHS Recovery Plan which is backed by more than £1bn of investment over the next five years. The plan takes forward our aim of increasing NHS capacity by at least 10% as quickly as possible in order to address the backlog of care and meet the ongoing healthcare needs for people across the country.

The Scottish Government considers a range of data to support policy development. Current data on how Scotland compares to the rest of the UK is considered in the weekly state of the epidemic paper, available on the Scottish Government website. This report ( Coronavirus (COVID-19): state of the epidemic - gov.scot (www.gov.scot) ) brings together the different sources of evidence and data about the COVID epidemic to summarise the current situation, and incorporates data from the UK COVID Dashboard on cases, hospital occupancy and deaths across the four nations. The Scottish Government also refers to the latest data for the four nations from the ONS Covid-19 Infection Survey, which includes estimates of positivity, estimates of the number of people testing positive for antibodies to COVID and long COVID, and has done since the first results were published for Scotland in October 2020.

The evidence and data which informs the Scottish Government is drawn from academic institutions based across the UK which inform SAGE (including via its sub-groups), the UK Health Security Agency and scientific literature from across the world. SAGE includes experts from within government and leading specialists from the fields of healthcare and academia. During the response to the COVID-19 pandemic the SAGE sub groups include:

• New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG)
• Scientific Pandemic Influenza Group on Modelling (SPI-M)
• Independent Scientific Pandemic insights Group on Behaviours (SPI-B)
• COVID-19 Genomics UK (COG-UK)
• Health Data Research UK (HDR UK)

The Heart Disease Action Plan 2021, sets out a strategic vision to address the impact of heart disease across Scotland. This means that the plan does not provide detailed information on specific conditions but instead identifies four priority areas. These are 1) tackling risk factors, 2) ensuring timely and equitable access to diagnosis, treatment and care, 3) addressing key issues within the cardiac workforce, and 4) ensuring effective use of data to support improvement.

The actions within these priority areas should impact across a number of cardiac conditions and therefore improve services for everyone with heart disease, including for people living with heart valve disease.